Prosecution Insights
Last updated: May 29, 2026

Societe D'Exploitation De Produits Pour Les Industries Chimiques Seppic

5 pending office actions • 4 art units • 4 examiners • 0 of 5 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Portfolio Summary

5
Total Pending OAs
3
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
1
Due this week
2
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 7 days (1)Due ≤ 30 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
2
Medium (40%)
0
Easy (0%)
3
Unknown (60%)

Rejection Statute Mix

BucketCases
§103 only2 (40%)
No statute on record3 (60%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HARRIS, BRITTANY SHARON 2 51.9% +32.9%
WELLES, COLMAN THOMAS 1 33.3% +76.9%
SONG, JIANFENG 1 56.1% +33.5%
PIPIC, ALMA 1 54.5% +55.6%

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
17632664 PHARMACEUTICAL COMPOSITION FOR TOPICAL USE THAT IS IN THE FORM OF A DISPERSED PHASE BASED ON AT LEAST ONE SHORT DIOL IN A CONTINUOUS FATTY PHASE AND COMPRISING AT LEAST ONE ANTI-INFLAMMATORY SUBSTANCE SONG, JIANFENG 52d overdue
18260300 DETERGENT COMPOSITION COMPRISING, AS THICKENING AGENT, A COMPOSITION HAVING POLAR MEDIA THICKENING PROPERTIES HARRIS, BRITTANY SHARON 46d overdue
18256562 LIQUID DETERGENT COMPOSITION FOR HOUSEHOLD OR INDUSTRIAL USE COMPRISING A POLYMER IN THE FORM OF A PULVERULENT SOLID AS THICKENING AGENT HARRIS, BRITTANY SHARON 7d
18260177 COMPOSITION COMPRISING POLYMERS OF NATURAL ORIGIN AND HAVING PROPERTIES FOR THICKENING POLAR MEDIA WELLES, COLMAN THOMAS 12d
17601325 PHARMACEUTICAL COMPOSITION FOR TOPICAL USE COMPRISING AT LEAST ONE AZOLATED LOCAL ANTIFUNGAL SUBSTANCE PIPIC, ALMA 26d

Top Art Units

Art UnitApps
1761 2
1612 1
1613 1
1617 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18260300 DETERGENT COMPOSITION COMPRISING, AS THICKENING AGENT, A COMPOSITION HAVING POLAR MEDIA THICKENING PROPERTIES HARRIS, BRITTANY SHARON 1761 §103 Final Rejection 46d overdue Pending Jul 03, 2023
18260177 COMPOSITION COMPRISING POLYMERS OF NATURAL ORIGIN AND HAVING PROPERTIES FOR THICKENING POLAR MEDIA WELLES, COLMAN THOMAS 1612 Other Non-Final OA 12d Pending Jun 30, 2023
18256562 LIQUID DETERGENT COMPOSITION FOR HOUSEHOLD OR INDUSTRIAL USE COMPRISING A POLYMER IN THE FORM OF A PULVERULENT SOLID AS THICKENING AGENT HARRIS, BRITTANY SHARON 1761 §103 Non-Final OA 7d Pending Jun 08, 2023
17632664 PHARMACEUTICAL COMPOSITION FOR TOPICAL USE THAT IS IN THE FORM OF A DISPERSED PHASE BASED ON AT LEAST ONE SHORT DIOL IN A CONTINUOUS FATTY PHASE AND COMPRISING AT LEAST ONE ANTI-INFLAMMATORY SUBSTANCE SONG, JIANFENG 1613 Other Final Rejection 52d overdue Pending Feb 03, 2022
17601325 PHARMACEUTICAL COMPOSITION FOR TOPICAL USE COMPRISING AT LEAST ONE AZOLATED LOCAL ANTIFUNGAL SUBSTANCE PIPIC, ALMA 1617 Other Non-Final OA 26d Pending Oct 04, 2021

Managing Societe D'Exploitation De Produits Pour Les Industries Chimiques Seppic's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month